MedTrace Logo

Targeted AntiBiotics for Chronic Pulmonary Diseases

NCT03262142 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2023-05-25

No results posted yet for this study

Summary

This is a prospective, randomized multi-center trial investigating the impact of lower airway infection with P. aeruginosa in COPD patients. The aim of the study is to evaluate if targeted antibiotic therapy against P. aeruginosa can improve the prognosis in patients with COPD. non-CF bronchiectasis (BE) and asthma.

Conditions

Interventions

DRUG

Piperacillin/tazobactam

Intravenous Piperacillin/tazobactam four times daily

DRUG

Ciprofloxacin

Oral Ciprofloxacin twice daily

Sponsors & Collaborators

  • Center for Genomic Medicine, Rigshospitalet, Denmark

    collaborator UNKNOWN

  • Chronic Obstructive Pulmonary Disease Trial Network, Denmark

    lead OTHER

Principal Investigators

  • Jens-Ulrik Jensen, MD, Consultant, Phd · Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2023-03-01
Completion
2023-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03262142 on ClinicalTrials.gov